Slower titration schedules and lower starting doses are possible with compounded medications, potentially reducing GI side effect risk in IBD populations
Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, Biasco G, Hugenholtz PG, Rizzon P
The Lancet, 397(10286), 17361748
Comparison Between Weight Loss Surgery vs GLP-1s Weight Loss Outcomes The difference in outcomes is very apparent when GLP-1s are compared to bariatric surgery , the latter leads to 23-35% total body weight loss and patients are able to maintain these results with healthy routines and good diets for decades, whereas GLP-1s deliver around 10-15% weight loss and can only be maintained with constant doses over a period of time
GLP-1 receptor agonists enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite
Research and development practice of traditional Chinese medicine based on network target theory and technology